EX-FILING FEES 3 ex107.htm

 

EXHIBIT 107

 

Calculation of Filing Fee Tables

S-1
(Form Type)

 

VICAPSYS LIFE SCIENCES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

Title of each Class of
Securities To be Registered
  Amount to be
registered (1)
   Proposed
maximum
Offering price
per share (2) (3)(4)
   Proposed
maximum
aggregate
Offering price (1)(2)
   Amount of
registration fee (3)
 
Common Stock, $0.001 par value per share, to be offered by the issuer (4)      $   $7,475,000   $823.75 
Shares of Common Stock issuable upon exercise of the Representative’s Warrants (5)           $         $467,188   $51.48 
                     
Total           $7,942,188   $875.23 
Registration Fee Previously Paid                 $- 
Registration Fee Paid Herewith                 $875.23 

 

(1) Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
   
(2) Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, stock dividends or similar transactions.
   
(3) Calculated under Section 6(b) of the Securities Act as .0001102 times the proposed maximum aggregate offering price.
   
(4) Includes the aggregate offering price of additional shares that the underwriters have the right to purchase from the Registrant, if any.
   
(5) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The representative’s warrants are exercisable for up to the number of shares of common stock equal to 5% of the aggregate number of shares (or pre-funded warrants in lieu thereof) sold in this offering at a per share exercise price equal to 125% of the public offering price of the shares. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative’s warrants is $467,188, which is equal to 125% of $373,750 (5% of the proposed maximum aggregate offering price of $5,750,000).